VITA — Vitaminka AD Prilep Income Statement
0.000.00%
Last trade - 00:00
- MKD744.34m
- MKD2.27bn
- MKD3.65bn
- 44
- 81
- 64
- 71
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,144 | 2,283 | 2,351 | 2,824 | 3,651 |
Cost of Revenue | |||||
Gross Profit | 763 | 765 | 805 | 795 | 872 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,083 | 2,233 | 2,285 | 2,704 | 3,530 |
Operating Profit | 60.6 | 50.2 | 66.5 | 120 | 121 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 35 | 19.9 | 29.3 | 83.2 | 75.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.8 | 18.1 | 25.8 | 76.2 | 69.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 28.8 | 18.1 | 25.8 | 76.2 | 69.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 28.8 | 18.1 | 25.8 | 76.2 | 69.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 522 | 263 | 362 | 953 | 907 |
Dividends per Share |